The relationship between the level of soluble CD40 ligand and angiographic extent and severity of coronary artery disease

IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Cor et vasa Pub Date : 2023-06-20 DOI:10.33678/cor.2022.132
B. C. Elçioğlu, Şükrü Taylan Şahin, E. Bozcali, S. Himmetoglu, H. Yüksel
{"title":"The relationship between the level of soluble CD40 ligand and angiographic extent and severity of coronary artery disease","authors":"B. C. Elçioğlu, Şükrü Taylan Şahin, E. Bozcali, S. Himmetoglu, H. Yüksel","doi":"10.33678/cor.2022.132","DOIUrl":null,"url":null,"abstract":"Objectives: Previous studies have suggested that atherosclerosis is a chronic infl ammatory disease and impli-cate components of the immune system in atherogenesis. The CD40 and CD40 ligand system regulates mul-tiple phases of the humoral and cellular immune response. Soluble CD40 (sCD40) ligand especially releases from activated platelets. Platelets are involved not only in thrombosis, but also in atherosclerotic lesion formation and restenosis processes. The aim of our study is to evaluate whether there is a relationship between the level of sCD40 ligand and angiographic extent and severity of coronary artery disease (CAD) and to compare other cardiovascular risk factors. Methods: 102 participants were included in our study. Among them, 37 patients constituted acute coronary syndrome (ACS) group, 41 patients were diagnosed as stable angina pectoris group (SAP), while 24 subjects served as control group. Peripheral venous blood samples were drawn at the Coronary Care Unit admission of ACS group patients. From SAP group patients and controls who have normal coronary arteries, blood samples collected after coronary angiography. The Gensini score was computed for each patient by assigning the severity score to each coronary stenosis in accordance with the degree","PeriodicalId":10787,"journal":{"name":"Cor et vasa","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cor et vasa","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33678/cor.2022.132","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Previous studies have suggested that atherosclerosis is a chronic infl ammatory disease and impli-cate components of the immune system in atherogenesis. The CD40 and CD40 ligand system regulates mul-tiple phases of the humoral and cellular immune response. Soluble CD40 (sCD40) ligand especially releases from activated platelets. Platelets are involved not only in thrombosis, but also in atherosclerotic lesion formation and restenosis processes. The aim of our study is to evaluate whether there is a relationship between the level of sCD40 ligand and angiographic extent and severity of coronary artery disease (CAD) and to compare other cardiovascular risk factors. Methods: 102 participants were included in our study. Among them, 37 patients constituted acute coronary syndrome (ACS) group, 41 patients were diagnosed as stable angina pectoris group (SAP), while 24 subjects served as control group. Peripheral venous blood samples were drawn at the Coronary Care Unit admission of ACS group patients. From SAP group patients and controls who have normal coronary arteries, blood samples collected after coronary angiography. The Gensini score was computed for each patient by assigning the severity score to each coronary stenosis in accordance with the degree
可溶性CD40配体水平与冠状动脉病变程度及严重程度的关系
目的:先前的研究表明,动脉粥样硬化是一种慢性炎症性疾病,并在动脉粥样硬化的形成中涉及免疫系统的组成部分。CD40和CD40配体系统调节体液和细胞免疫反应的多个阶段。可溶性CD40(sCD40)配体特别是从活化的血小板中释放。血小板不仅参与血栓形成,还参与动脉粥样硬化病变的形成和再狭窄过程。我们研究的目的是评估sCD40配体水平与冠状动脉疾病(CAD)的血管造影范围和严重程度之间是否存在关系,并比较其他心血管风险因素。方法:102名参与者被纳入我们的研究。其中急性冠状动脉综合征组37例,稳定型心绞痛组41例,对照组24例。ACS组患者在冠状动脉监护室入院时采集外周静脉血样。来自SAP组患者和冠状动脉正常的对照组,冠状动脉造影后采集的血液样本。通过根据冠状动脉狭窄程度将严重程度评分分配给每个患者,计算每个患者的Gensini评分
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cor et vasa
Cor et vasa CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
0.50
自引率
50.00%
发文量
66
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信